
AI (GPT4) ãšæ¥œããåŠäŒçºè¡šçšãã¯ãŒãã€ã³ãã¹ã©ã€ããäœæãããChatGPTãšäžç·ã«äœãããšã§æéççž®ãç®æããŸãã
0. ã¯ããã«
ChatGPT (AI) ãçšãããã¯ãŒãã€ã³ããã¬ãŒã³ã¹ã©ã€ãã®äœæã泚ç®ãããŠããŸããChatGPTã«ããèªåäœæ, ChatGPTãããã¬ãŒã³ã¢ã€ãã¢ãããããªã©çšéã¯å¹ åºãã§ããããæ°ãæã®AIã®é²åã¯ãããŸããåå玹ä»ããèšäºã¯å®å šã«æä»£é ãã«ãªããŸããããŸãAIãããŸãã¡æ®åããŠããªãçç±ãšããŠç޹ä»ãããææ³ã§å®è·µããŠãããŸãã¡å¹çåãæããããªãã£ããªã©ã倧ããã®ã§ã¯ãªãããšå人çã«èããŠããŸãã
ä»åã®ããŒããšããŠAI ãäžåŸæãªããšã¯å²ãåã£ãŠåŸæãªããšãã ãã«æ³šç®ãåºæ¥ãã ãå¹ççã«åŠäŒçºè¡šã§çšããã¹ã©ã€ãã®äœæãç®çãšããŸãããGPT4ãæŽ»çšããçŸæç¹ã§æéãšå人çã«èããŠããŸãã¹ã©ã€ãäœæã玹ä»ããããšæããŸãã
1. æ¹æ³, æºå
1.1 ã¹ã©ã€ãäœæã®æ¹æ³
ãããŸã§äž»ã«è©ŠããŠã¿ãŠè¯ãã£ãã¹ã©ã€ãäœæã¯ä»¥äžã®éãã§ãã

â ãš â¡Â ã¯ChatGPTãšãã¯ãŒãã€ã³ãã§ã»ãŒå®çµããææ³ã§ããäž»ã«åæ¡ã®ã¿ãGPTã«èããŠ, å®éã®äœæã¯ãã¯ãå
ã§æåã§è¡ããŸãã
⢠⣠ã¯å°çšã®AIæ¯æŽã¹ã©ã€ãäœæããŒã«ã䜿çšããæ¹æ³ã§ãã
åèªåã§é«å質, ãã¶ã€ã³æ§ã®åªããã¹ã©ã€ããäœæã§ãçè
ãGammaAIã«èª²éãããäžææ©ã¿ãŸãããææãœããã§ããããš, äœãæ¹ãäžããåŠã°ãªããšãããªããšãããã¡ãªããããããŸãã
†Advanced Data Analysis (æ§Code Interpreter)
å®è³ªå
šèªåã§éåžžã«é«å質, ãã¶ã€ã³æ§ã®åªããã¹ã©ã€ããäœæå¯èœã§ããå°æ¥æ§ã¯æé«ã§ãã, çŸæç¹ã§ã¯ã³ãŒããäœãæéãèšå€§, ãšã©ãŒãå€ãäžåã«äœæã§ããã¹ã©ã€ããå°ãªããªã©å®çšæ§ãå
šããããŸããã
ãããã®ææ³ã100ç¹æºç¹ã§è©äŸ¡ããŠãã ãããè©äŸ¡é
ç®ã¯ 1. èªåå, 2. äœæã®éã,
3. å®å®æ§/ãã°, 4. æè¡ã¬ãã«, 5. æ±ããããã§ããããã«6. å
šäœã®å¹çã以äžã«å®çŸ©ããŸãã
å
šäœã®å¹ç= (äœæã®éã à 2 + å®å®æ§/ãã° Ã 2 + æè¡ã¬ãã« Ã 1 + æ±ãããã à 2) / 7ãããã®ææ³ãå¹çåã®èгç¹ãã, ãŸã, èªååã®èгç¹ããè©äŸ¡ããŸãããå šäœã®å¹çã¯çè ãèããåŒã§äœã®æ ¹æ ããããŸãã⊠GPTã«è©äŸ¡, ç¹æ°åããŠãããå人çãªäž»èгã§åŸ®èª¿æŽããŸããã

çè ã®ãã€ã¢ã¹ã圱é¿ããçµæã§åœç¶ãšèšãã°åœç¶ â GPT4ã§åæ¡ãèããã®ãäžçªå¹ççãªçµæãšãªããŸããããã®çµæãx軞ã«èªååã®çšåºŠ(Automation), y軞ã«å¹çå (Efficacy) ãåã, Advanced Data Analysis (以äžADA) ã§æ£åžå³ã°ã©ãã«ããŠããããŸããã

AIæ¯æŽããŒã«ãæãåªç§ã§ããç¡æ (GPT4ã䜿ã£ãŠããæç¹ã§ç¡æã§ã¯ãããŸãããâŠ) ã§è¡ããªã â GPT4ã§åæ¡ãããããã®çµæãšãªããŸããããšãããç¡çããïŒããŸããã
ãã¬ãŒã³ã«äœ¿ãæ¿çµµãç»åãAIã§äœæããããšèããŠããããã¯è¯ãã£ããâã®èšäºãåèã«ããŠãã ããã
1.2 æºå
ä»åãéãªæ£è æ å ± (éé¢ãµããªãŒ) ãããšã«çºè¡šçšã¹ã©ã€ããäœæããããšæããŸãã以åã®noteèšäºã§äœæãããèºåžè«çãã®çäŸã§åã³äœã£ãŠã¿ãããšæããŸãã

ãã®æ¶ç©ºçäŸãããšã«ChatGPTã«ã©ã³ãã ãªèšå®ãäžããŠããããŸãããããã«ããã€ã倿Žç¹ãå ãé颿ãµããªãŒãäœæããŸãããâ»å®éã®æ£è æ å ±ã§è¡ãã®ãäžçªå ·äœçã§ããããããã®ã§ããå人æ å ±ä¿è·ã®èгç¹ããæ¶ç©ºçäŸã«ããŸããã

宿Šãæ³å®ãæ¢ããŠèª€å, è±å, ç¥èªãå«ã, å 容ãäœqualityãªãã®ã«ããŸããã
2. äœæ ã¿ã€ãã«-å ¥é¢åŸçµéãŸã§
2.1 ã¿ã€ãã«-䞻蚎, çŸç æŽ
ã¿ã€ãã«ãèããŠãã ãããCovid-19眹æ£åŸã«åå äžæã®èºçç¶ã«å¯Ÿãèºåžè«çãšèšºæããã¹ããŒãªãŒã§
è±èªã®ã¿ã€ãã«ããé¡ãããŸãã A case ïœ folloingïœã§ãé¡ãããŸãããA Case of Paragonimiasis Following Persistent Pulmonary Symptoms Post-COVID-19ãããããã¡ãªç¡é£ãªã¿ã€ãã«ã§äœæããŸãã
çŸç
æŽããã³ãã
ããããã«ã«ãåæãã以äžã®æ¡ä»¶ãããšã«ãçŸç
æŽããäœæããŠãã ãããåŸã§ã«ã«ãåæãæç€ºããŸãã®ã§okã®ã¿è¿ããŠäžããã
æ¡ä»¶
ã»200æåçšåºŠã§èšè¿°ããŠäžããã
ã»âã¯ã«ã«ãåæã®å
容ãåç
§ãæååã§çœ®æããŠãã ããã
ã»å»åŠçšèªã䜿çšãäŸãšããŠãåã®çã¿ã¯ãåœé çããæ¯èŠããã¯ãåŒåžèŠãã
ãµãã¶ãã®çã¿ã¯ãé¢ç¯çããšè¡šçŸããŸããç±ããŸãã¯ãè§£ç±é®çè¬ã
ã»å
¥é¢ã«è³ãçµç·¯ã«ã€ããŠèšèŒããæåŸã®è¡ã¯ã粟æ»å çã®ããâæâæ¥ã«âãžå
¥é¢ãšãªã£ããã
ã»åžžäœã§èšè¿°ïŒã§ããŸã調ã§ã¯ãªãïŒ
ã»éå»åœ¢ã§èšè¿°ã(ïœãã, ïœã§ãã£ã, ïœããã)
ã»æ£è
ã®èŠç¹ããèšè¿°, åºæ¬çã«ã¯ååæ
ã§ãïœããã ïœãåãããïœãšææããã
ã»èªãã, ã«ãŠ ãšããèªå¥ã䜿çšããªã
ã»â幎âæâæ¥ã§çµ±äž åã幎ã¯ç¹°ãè¿ããªãã2åç®ãããå幎âæâæ¥ã
ã»âç
é¢, âå»çã»ã³ã¿ãŒ, âã¯ãªããã¯ãªã©ç
é¢åãå®åã§èšè¿°ãããŠããããè¿å»ã, ãŸãã¯ãåå»ãã«å€æŽ
ã»é¢šéªè¬ãªã©è¬ååãå
·äœçã§ãªãã㰠颚éªè¬ (è©³çŽ°äžæ) ãšèšè¿°
ã»è¬åã¯äžè¬åãäŸïŒããã¢ãã¯ã¹âã»ãã«ãã³ãããã·ã«å¡©é
žå¡©
ç¥èªã¯å
šç§°ã«åæ§ç¯ãäŸïŒãªã°ãµã¯âãªãŒã°ã¡ã³ãã³/ãµã¯ã·ãªã³
ã»ããã®çµæããšãã衚çŸã¯äœ¿ããªã
ã»ãæ€æ»ã§ïœãèŠãããããšãã衚çŸã¯äœ¿ããªãããæ€æ»ã§âã®æèŠãææãããããããâãçããããããæ€æ»ã§âãçãããããªã©ãšãã
ã
ã»ç²Ÿæ»ãšæ²»çâ粟æ»å ç
ã»é«è¡å§âé«è¡å§ç, èç³âèç³ç
ã»ãæ¥ã«ãâãçªç¶ã, ãçŸãããâãåºçŸãããéé¢ãµããªãŒã®çŸç æŽãå«ãŸããç®æãã³ããããŸãã


ãŸããŸãã®æç« ãåºåãããŸãããæªãããšããããããŸãã®ã§åŸã§äººéã®æã§ä¿®æ£ãå¿ èŠã§ããã
2.2 æ€æ»æèŠ, å ¥é¢æçŸç, ãã®ä»
æ€æ»æèŠã以äžã®äŸã«ãªãã£ãŠé£ç¶ããæååã§åºåããŠãã ããã
äŸïŒèµ€è¡ç âäž/ÎŒL, Hb â g/dL,ã»ã»ã»
GPTã䜿ãæå€§ã®å©ç¹ã®äžã€ã§ããæå ¥åããè§£æŸãããŸãããããŸããããªãå Žåã¯ãäžå¯§ãªããã³ããããå¿ èŠã«ãªããããããŸããã以äžã«ããã³ããäŸã眮ããŠããŸãã
nè¡2åã®è¡šãäœæããŠãã ããã
äŸïŒ1è¡1å AST 1è¡2å 55 U/LGPTã¯ããã©ã«ãã§è¡šäœæã®èœåããããŸããããã³ããã¯ç°¡æãªãã®ã§éããããšãå€ãã§ãã

GPTãäœã£ã衚ã¯ã³ããããããšã§Excel, PowerPointãšäºææ§ããããã®ãŸãŸæµçš, åç·šéã§ããŸãã

åŒãç¶ããå ¥é¢æçŸçããäœæããŠããããŸãã
å
¥é¢æçŸçããã³ãã
ããããã«ã«ãåæãã以äžã®æ¡ä»¶ãããšã«ãå
¥é¢æçŸçããäœæããŠãã ãããåŸã§ã«ã«ãåæãæç€ºããŸãã®ã§okã®ã¿è¿ããŠäžããã
æ¡ä»¶
ã»äŸããã®ãŸãŸåŒçšãããã®äžã§ç°åžžæèŠã倿ã远èšããã
ã»âã¯ã«ã«ãåæã®å
容ãåç
§ãæååã§çœ®æããŠãã ãããèšèŒããªããã°âã®ãŸãŸã
ã»å»åŠçšèªã䜿çšãäŸãšããŠãåã®çã¿ã¯ãåœé çããæ¯èŠããã¯ãåŒåžèŠãã
ãµãã¶ãã®çã¿ã¯ãé¢ç¯çããšè¡šçŸããŸãã
ã»åžžäœã§èšè¿°ïŒã§ããŸã調ã§ã¯ãªãïŒ
ã»æèŠãããå Žåã¯ãïœãèªãããããªãå Žåã¯ãïœã¯ãªãããšèšè¿°ããäžæããšããèšèã¯äœ¿ããçç¥ããŠãã ãã
ã»ãã®ä»èº«äœæèŠã®å
·äœäŸ 以äžã®äŸãã«ã«ãåæã«æèšãããŠããã远èšããŠãã ããããªããã°çç¥ããŠãã ããã
ïŒJCS, GCS, ç³ååŸ, CVA婿çã®æç¡ãåºéã®æç¡ æè¡åµã®æç¡, è
žè åé³, PS, é¢ç¯ã®å§ç, è
«è¹,
ãªã³ãç¯ã®èç¥, ç¥çµåŠçæèŠ, æ§é³é害, å
±ååèŠ, 空éç¡èŠã®æç¡, MMT (äŸãã°äžè§ç4)ã, é·è°·å·åŒç¥èœè©äŸ¡ã¹ã±ãŒã«
ã»æ¹è¡, 空çœã¯äžèŠã§ããé£ç¶ããæååã§åºåããŠãã ããã
äŸïŒãå
¥é¢æçŸçãèº«é· â cmïŒäœé â kgïŒäœæž© ââïŒèæ â /åïŒæŽïŒè¡å§ â/âmmHgïŒåŒåžæ° â /åïŒçŒçŒçµèã«è²§è¡ã¯ãªãïŒçŒççµèã«é»çžã¯ãªãïŒèžéšïŒèºé³ïŒå¿é³ã«ç°åžžã¯ãªãïŒè
¹éšïŒå¹³åŠïŒè»ã§å§çã¯ãªãïŒèã»èŸãè§Šç¥ããªãïŒåè¢ïŒäžè
¿æµ®è
«ãèªããªãïŒç®ç¹ãèªããªã.2.3 ãã®ä»ã®æ€æ»ãç»åæ€æ» CT
ç»åæ€æ» (CT, ãšã³ãŒ) ãªã©ã®çµæã¯æ®å¿µãªããæåã§è²Œãä»ãããããããŸãããããã, GTPãšç»åæèŠã«ã€ããŠå¯Ÿè©±ããããšã¯å€§ããªæå³ããããŸãã CTæèŠããã®èšºææ§èœã®é«ãã¯ä»¥åããæ³šç®ãããŠããŸãã
éé¢ãµããªãŒã®ãCTæèŠããã³ããããŸãã
CTæèŠãããã®æ£è
ã®æ³å®ãããçŸæ£ã確çãšãšãã«æç€ºããŠãã ããã
ãåçŽèžéšCTæèŠã
å³äžèºèã«å¢çäžæçãªçµç¯åœ±ã確èªã該åœéšäœã«ã¯å
éšæ§é ã®å€åãå¯åºŠç°åžžãªã©ã®ç¹çãã¹ãæèŠã¯èªããªãã
å·Šäžèºèã«æ¡æ£æ§ã®æµžæœ€åœ±ã確èªããããåšèŸºã«è»œåºŠã®ã¹ãªã¬ã©ã¹åœ±ã䌎ã£ãŠããã
äž¡åŽèžè
ã«ã¯è»œåºŠã®èžæ°Žè²¯çãå³åŽèžæ°Žã®åãã¯çŽ2cmãå·ŠåŽã¯çŽ1.5cmãšèšæž¬ãããã
ãã®ä»ã倧ããªæ°èžãçµè·¯ã®ç¹å®ã§ãããªã³ãç¯è
«å€§ãªã©ã®æèŠã¯èªããªãããææçã çŽ°èæ§èºç - 25% ãŠã€ã«ã¹æ§èºç - 20% èºçµæ ž - 15% èºåžè«çãä»ã®å¯çè«ææç - 5% çèæ§èºçïŒäŸ: ã¢ã¹ãã«ã®ã«ã¹çãã¯ãªããã³ãã«ã¹çïŒ- 10% PJPïŒæ§ç§°ïŒPCPãPneumocystis jiroveciièºçïŒ - 10%
ãè åç /è¡ç®¡ççå矀ã å šèº«æ§ãšãªããããŒãã¹ïŒSLEïŒ - 5% èºç·ç¶çã䌎ããªãŠããæ§èºçŸæ£ - 5% ã·ã§ãŒã°ã¬ã³çå矀ã«é¢é£ããèºçŸæ£ - 5% ANCAé¢é£è¡ç®¡ç - 3%
ãè «çã èºè ºç - 10% èºæå¹³äžç®ç - 5% ã¡ãœããŒãªã§ãŒãïŒèžèã®æªæ§è «çïŒ - 3% èºè»¢ç§»è «ç - 7%
ããã®ä»ã é質æ§èºçŸæ£ïŒäŸ: éææ§èºçãèºç·ç¶çïŒ - 10% ã¢ã«ãŽã§ãªã©ãŒãããã€ã³ãŒã·ã¹ - 5% è¬ç©èªçºæ§èºçŸæ£ - 5% ã¢ã¹ãã¬ãŒã·ã§ã³ - 5%
ææçãçãããŠããŸãã
2.4Â å ¥é¢åŸçµé
2.4.1 Problem Listãšéå¥èšºæ
ãããã¬ã ãªã¹ããšéå¥èšºæãåæã, ãã®çäŸããçãçŸæ£ãæããŠããããŸããåãChatæ¬ã§ç¶ããŠè³ªå (ããã³ãã) ããã°ããçšåºŠèŠããŠãããŠããŸãã®ã§æ¹ããŠæ£è
æ
å ±ãã³ããããå¿
èŠã¯ãããŸããã
æ£è
èæ¯, èº«äœæèŠ, è¡æ¶²æ€æ», çµé, CTæèŠãå å³ããæã®çŸæ£ã®å¯èœæ§ãåè©äŸ¡ããŠãã ãããææç
çŽ°èæ§èºç: æ¢ã«åæèšºæãããŠãããCTæèŠããããæ¯æããŠãããäºå確çã¯éåžžã«é«ãããããã70%ã
çµæ ž: åºèº«å°ãšäœå± ã®èæ¯ããçãããŸããããæé²æŽã¯ãªããšã®ããšãCTæèŠãç¹å®ã§ãããªã³ãç¯è «å€§ãªã©ã¯ãªããäºå確çã¯äœãããããã10%ã
è åç /è¡ç®¡ççå矀
å šèº«æ§ãšãªããããŒãã¹ïŒSLEïŒ: ç¹å®ã®æ¢åŸçãçç¶ããªããããäºå確çã¯äœãããããã5%ã
èºç·ç¶çã䌎ããªãŠããæ§èºçŸæ£: æ¢åŸçãçç¶ããªããããäºå確çã¯äœãããããã5%ã
å ¥é¢æã®åæèšºæãšããŠã¯çŽ°èæ§èºçãçããããšã®ããšã§ãã
æããChatGPTã¯å»åŠçãªProblem Listäœæãå ¥é¢åŸçµéã®èª¬æãæžããã¬ãŒãã³ã°ãåããŠããªãããèŠæã§ããChatGPTã«ããŠãããä»äºã¯ãããŸã§åæ¡ã®äœæã§ããæ¬¡ã«éå¥èšºæã§ãã
ãã®æ£è
ã§éèŠãªéå¥èšºæãã5ã€æããŠäžãããåºæºãšããŠã¯å¯èœæ§ãé«ããã®,
èŠèœãšããšèŽæ»çã«ãªãçŸæ£, ç¹ç°ççç¶, æ€æ»ããçãããçŸæ£ãªã©ã
説æã¯äžèŠã§çµæã®ã¿ãç®æ¡æžãã§åæããŠãã ããã
ãŸãã¢ã»ã¹ã¡ã³ãã以äžã®äŸã«åŸã£ãŠäœæããŠãã ããã
äŸïŒå
¥é¢æâãèªã, âããäžèšâãªã©ãçã£ããéèŠãªéå¥èšºæ:
1. çŽ°èæ§èºç
2. Covid-19é¢é£ã®å䜵çã»åŸéºç
3. PJP (Pneumocystis jiroveciièºç)
4. è¬ç©èªçºæ§èºçŸæ£
5. é質æ§èºçŸæ£
ã¢ã»ã¹ã¡ã³ã: å ¥é¢æåŽäœæã®åŒåžèŠãšççåå¿ã®é«å€ãèªããèºã®æµžæœ€åœ±ãšäž¡åŽèžè ã®è»œåºŠã®èžæ°Žè²¯çããäžèšã®çŽ°èæ§èºçãCovid-19é¢é£ã®å䜵çã»åŸéºçãªã©ãçã£ãã
2.4.2 å
¥é¢åŸçµéãšè¡š
1æã§äž»èŠæ€æ», 䜿çšããæ²»çè¬ãæç³»åã«ãŸãšããå³è¡šãäœæãããã§ãã, çŸæç¹ã§AIã§èªåäœæã¯äžå¯èœã§ããã«ç¹åããå°çšãœãããå¿
èŠãšèããŠããŸããäžå¿, ADA (Code Interpreter)ã§è€éãªã°ã©ãã¯å®å
šèªååã§ããŸãã, excel ã«çŽæ¥åºåã§ããç»ååºåãšãªãããåç·šéã§ããŸããã以å玹ä»ããæ¹æ³ã§äœã£ãŠã¿ãŸããã
2軞æãç·ã°ã©ããäœæããŠãã ãããpython codeã¯åŸã§æç€ºããŸãã
CRP [mg/dL] WBC [/uL]
8/1 3.0 12500
8/3 5.2 13100
8/5 6.2 11000
8/8 5.7 12200
8/11 3.2 9850
8/13 1.2 75502軞æãç·ã°ã©ãã®codeãå ¥åããŠã§ããã°ã©ãã§ãã

æåãæšå¥šããŸãã
2.4.3 å
¥é¢åŸçµéÂ
ãšããããã§å³è¡šã§èª¬æããæ¥æ¬èªç®æ¡æžãã§èšè¿°ããŸããChatGPTãšå¯Ÿè©±ããŠå
¥é¢åŸã®æ€æ», æ²»çã«ã€ããŠäžç·ã«èããŸãããŸãã¯éé¢ãµããªãŒã®ãå
¥é¢åŸçµéããã³ããããŸãã
ãå
¥é¢åŸçµéããšããŸãŸã§ã®ãããšãã§ãã®æ£è
ã®èšºæ, æ²»çã«ã€ããŠäžç·ã«èããŠãã ããããã®æ£è
ã¯FilmArrayã§ãç¹å®ã§ããŸããã§ããããŸãæé
žèãåŠå®çã§ããã
çŽ°èæ§èºç, ãŠã€ã«ã¹èºçãçã£ãŠCTRX, TAZ/PIPCãæäžãæ¹åããªããšããããšã§ããã
ãã®æ®µéã§çãã¹ãçŸæ£, è¡ãã¹ãæ€æ», å蚺ãã¹ãæ
å ±ã¯ãããŸããããè¡ã£ãæ€æ», æ²»çã®éžæã®åŠ¥åœæ§ã«ã€ããŠæ¬æ¥ã¯çºè¡šè userãèããã¹ãã§ããããã, ChatGPT4ã¯å»åŠçåé¡ã«ã€ããŠãã°ãã°é©åãªè§£çãå©èšããŠãããŸãã

å
¥é¢åŸã®è¿œå å蚺ã§, çç¶çºç1ã«æåã«ãã£ãªãã³ã§æ·¡æ°Žã«ããé£ã¹ãããšã倿ããŸããã
ãã®ã¿ã€ãã³ã°ã§ããã¹ãæ€æ»ãæ€æ»ã®æçšæ§ãæšå¥šåºŠ (æå€§100%)
話ãè±ç·ããŠããŸããŸãããããããã¹ã©ã€ãäœãã«æ»ãããã®ã§, äžæŠãããŸã§ããŸãšããŠ
ãŸãåŸã§è©±åããŸãããã
ãããŸã§ã®ããåããšãå
¥é¢åŸçµéããããèŠçŽããäœæããŠãã ããã7/25ã«è¿å»ã¯ãªããã¯ã§COVID-19æ€æ»ãåããéœæ§ãšèšºæãããã軜çã§ãã£ããããè§£ç±é®çè¬ãåŠæ¹ããçµé芳å¯ãšãªã£ãããçç¶ã¯æ¹åããæç¶ã8/1-14ãŸã§å ¥é¢ãèºåžè«çã®æ£è ã¯å ¥é¢æã«ççãšIgEã®é«å€ã瀺ããŠããããè åç ã瀺åããç¹å®ã®èæ¯ãèº«äœæèŠã¯èªããããªãã£ããåçŽCTã§ã¯èºã«å¢çäžæçãªçµç¯åœ±ã浞最圱ãäžéšããã¬ã©ã¹åœ±ã確èªãããææçãè åç ãæªæ§è «çãªã©ã®å¯èœæ§ãèæ ®ããããç¹ã«COVID-19ã®åŸéºçãåšè³ªåèºçãéå¥èšºæã®äžéšãšããŠèæ ®ããããæ§ã ãªæ²»çã詊ã¿ãã广ã¯åŸãããªãã£ããæ£è ããã£ãªãã³ã§èª¿çäžååãªæ·¡æ°Žã«ããæåããŠããããšãæããã«ãªããäŸ¿æ€æ»ã§èºåžè«ã®åµã確èªããããèºåžè«çãšèšºæãããã©ãžã«ã³ãã«ãæäžããçµæãçç¶ãæ¹åãã8æ14æ¥ã«éé¢ãšãªã£ãã
èŠçŽäœæ¥ã¯åŸæã§ããåŸã§åå©çšããŸãã
ãå
¥é¢åŸçµéãã®ã¹ã©ã€ãåæ¡ãäœæããŠãã ããã
æ¡ä»¶
ã»éå»åœ¢ã§äœæã
ã»ã§ããŸã調ã§ã¯ãªã ãïœã ã£ããïœãèªãããïœã§ãã£ããåžžæ
ã§
ã»ååæ
ã§ã¯ãªãèœåæ
ã§
ã»æç³»åããšã«èšè¿° Day1ïœãç®æ¡æžãã§ãªãé£ç¶ããæååã§ã
ã»ãã¹ãŠã®Dayãå«ãå¿
èŠã¯ãªã, 転æ©ãšãªãæ€æ», æ²»çä»å
¥ãè¡ã£ãDay
è¡ã£ãæ€æ»ã«é¢ããŠã¯ãããŸããªè¡šçŸã§ã¯ãªãå
·äœçãªæ€æ»åã§ã
ã»äœãçã£ãŠã©ãããæ€æ»ãè¡ã£ãããçç¶, æ€æ»å€ãªã©ããæ²»ç广ã«ã€ããŠã¢ã»ã¹ã¡ã³ãã
æ€æ»å€ã¯å
šãŠåæããå¿
èŠã¯ãªã蚺ææã®è©äŸ¡, çç¶ã®æªå, æ¹åãªã©ã§å¿
èŠãªãšãã«è¡šç€ºã
ã»ç¢ºå®èšºæ, 転垰ãå«ããã
ã»å
¥é¢ããéé¢ãŸã§ã
3. åèæç®æ€çŽ¢ åèš³
3.1 æç®æ€çŽ¢
åèæç®ãæ¢ããŠèš³ããŠãŸãšããäœæ¥ã¯èšå€§ã«æéãæ¶è²»ããŸããAI掻çšããããšã§æéççž®ãå¯èœãšãªããŸãããåãChatæ¬ã§ä»¥äžã®è³ªåãããŸã
ãããŸã§ã®ãããšããåŠäŒçºè¡šããããšæããŸãã蚺æãé
ããèºåžè«çãšããããŒãã§è©±ããŸãã
Pubmedã§æ€çŽ¢ãã¹ãwordãæç€ºããŠãã ããã
æç®ã®æ€çŽ¢æ¹æ³ãšããŠPubMedã§æåæ€çŽ¢, Perplexityãªã©ã®ããŒã«ã§AIã¢ã·ã¹ãæ€çŽ¢ãªã©ããããŸããã©ããäžé·äžçã§æ¥ã 暡玢ãããŠããŸããä»åã¯æè¿ãªãªãŒã¹ããã髿§èœãšåŒã³åã®é«ãPaperpile (Plugin) ãçšããŠAIæç®æ€çŽ¢ãæ€èšŒããããšæããŸãã
ä»åã®çäŸã«é¢é£ããä»ã®ç ç©¶å ±åãæ¢ããŠããããŸãã
delayed diagnosis Paragonimiasis Japanã5æ¬è«ææ¢ããŠãã ããã
ãã¡ããæ¶ç©ºè«æã§ã¯ãªãå®åšããè«æããªã³ã¯, èŠçŽä»ãã§æç€ºããŠãããŸãããããã, äœåã詊ããŠãããšé¢é£æ§ã®äœãè«æãæç€ºããããšããããŸããã

ãŸã, äœåºŠã䜿çšããŠãããšååšããªãæ¶ç©ºè«æãããããååšãããã®ããã«æç€ºããŠããŸããã

ãã¯ããã©ã°ã€ã³ã¯ããããåäœãäžå®å®ãªå°è±¡ã§ãã
æ¬é¡ã«æ»ããŸãã
æ¯èŒçšãªçŸæ£ã¯, æç§æžãã¬ã€ãã©ã€ã³ããªã, ãç·èª¬è«æ (Review article)ãã§å
šäœåãåŠã¶ããšãå€ããšæããŸãã
Review article ãæ¢ããŠãã ããã
3.2 æç®åèš³ (èŠçŽ)
èŠçŽããæ¹æ³ã¯ããã€ããããŸãã以åã¯ææã¡ã®pdfè«æãAsk YourPDF ãã©ã°ã€ã³ã§èªã¿èŸŒãŸãGPTã«é«åºŠãªæç« ãäœæã§ãããã©ããæš¡çŽ¢ããŠããŸããã
ã»Ask YourPDF (Plugins)

PaperPileã§æ€çŽ¢âèŠçŽãäžåºŠã§ã§ããæ§ã«ãªããŸããã®ã§ä»åã¯PaperPileã§è¡ããŸããå ã»ã©ã®listã®äžã«åœå ã®çäŸå ±åé, è¯ãããªè«æããããŸããã®ã§ãèŠçŽãããŠåŠç¿ (èªåãšGPT) ããŸãã
Paragonimiasis in Japan: a twelve-year retrospective case review (2001-2012).
ã詳ãã解説ããŠäžããããããGPT4 çŽ æŽãããèŠçŽã§ãããã¡ããå 容ã«é¢ããå»åŠçãªè³ªåã«ãç確ã«çããŠãããŸãã

3.3 æç®åèš³ (å šèš³)
3.3.1 DeepLã䜿ã£ãŠéšååèš³
1èŠçŽã¯äž»ã«GPTã«å
å®¹ãææ¡ããŠããããã, å
šèš³ã¯ãã¡ãuseråŽãå
šäœææ¡ããããšãã«äœ¿ãããšãå€ããšæããŸããä»ã®æ, ç¡æã§æ©ããŠæ£ç¢ºã«å
šèš³ãè¡ãããšãåºæ¥ãAIããŒã«ã¯DeepL翻蚳ãäžçªæåã§ã¯ãªãã§ãããã
ç¡æã§ã¯1500æåãŸã§äžåºŠã«ç¿»èš³ã§ããŸããç¡æäŒå¡ç»é²ããã°5000æå, ææäŒå¡ã«ãªãã°æåæ°ç¡å¶éãšãªããŸãã
è«æã®äžéšãã³ãããããšäžç¬ã§é«åè³ªã®æç« ã§åèš³ãããŸãã

è«æpdfãå¿ å®ã«åçŸããŠãããŸãã®ã§å ã®æç« ã«ãã£ãã圢åŒçãªæ¹è¡ããæ®ã£ãŠããŸãããã®åé¡ããããããªæ¹æ³ã§åé¿ã§ããŸããä»åã¯
ShaperãçšããŸãããDeepLã§ç¿»èš³ããã¯ãªãã¯ããã ãã§

æ¹è¡ããªããªãèªã¿ãããæç« ãåºåãããŸããã

äœåãç¹°ãè¿ãå šäœãåèš³ããŠãããŸãã
3.3.2 äžæ¬åèš³
PDFã®äžæ¬ç¿»èš³ãããœããã¯ããã€ããããŸãããç¡æã§ã¯Google翻蚳ãæåã§ããããã
ææã¡ã®è«æPDFãã¡ã€ã«ãã¢ããããŒãããŸãã

ãã®æ¹æ³ã§ã¯å ã®pdfã®åœ¢åŒã®ãŸãŸå šèš³ãããŸãã®ã§å³è¡šãäœçœ®ãåçŸãããŠããŸãã

ãã 翻蚳ã®ç²ŸåºŠãããŸãé«ããªãã®ã§ç²ŸåºŠãæ±ãããªãDeepL, é床, ã¹ã¿ã€ã«ãæ±ãããªãGoogle翻蚳ã§äžæ¬å€æã§ããããã
åèïŒãã®ä»ã§æçšãªããŒã« Perplexity AI
AIæèŒã®è«ææ€çŽ¢ããŒã«ã§ãããªã³ã¯ä»ãã§è«æãæç€ºããŠãããŸããããã«æç®ã«é¢é£ããçžè«ãªã©å¯Ÿè©±ããããšãå¯èœã§ããåºæ¬ç¡æ, æ¥æ¬èªãäžå¿å¯Ÿå¿ã

4. äœæ èå¯
4.1 æ§æãèãã
ChatGPTã«ããèå¯ããèããŠãã ããããªã©çãåœä»€ã§ãé¡ãããŠãããçšåºŠã®æç« ã¯äœæããŠãããŸããããã, é«åºŠãªæç« ãäœæããæã¯çè ã¯ãã°ãã°ãã©ã®ãããªæ§æãã§ãããšGPTèªèº«ã«èãæ¹æ³ãå ·äœçãªæ§ææ¡ããã¡ãããæç€ºãããªã©ããŠäœæããŠããŸãã
A Case of Paragonimiasis Following Persistent Pulmonary Symptoms Post-COVID-19ãšããã¿ã€ãã«ã§
çºè¡šãäºå®ããŠããŸããèå¯ããŒããäžç·ã«èããŠãã ãããçšãªçŸæ£ãšããããšã§æ§æã¯ã
1.ç·èš èºåžè«çã®äžè¬çãªæŠèŠã2.çç¶ 3. æ€æ», 蚺æ, CTæèŠ 4.æ²»ç
5.ä»ã®ç ç©¶ãšã®æ¯èŒ æèš(å蚺ã®éèŠã)ã蚺æã®å°é£ã CovidåŸ, 䌌ãŠããçŸæ£çµæ ž, æªæ§è
«çãªã©ã®
éå¥ããªã©
4.2 ç·èš, æŠèŠ, çç¶
æ¹æ³ãšããŠã¯ç·èª¬ãªã©ã®è«æãShaper+DeepLã§åèš³â(Wordã§ä¿å)âChatGPTã§èŠçŽãšããé¢šãªæµãã§ããåŒçšæç®ã¯ææã¡ããã®ã¯ãšãŠã
[J Y;V:P]ã®åœ¢åŒã§åºå
žå
J:Journal Y:year V:volume P:pageãäŸ [Intern Med 2023;1:1-5]骚ãæããäœæ¥ãªã®ã§äžã®ããã³ãããé »çšããŠããŸãã
ããšã¯ãã§ã, ãŸã調ãã§ã¯ãªããïœã§ããããšããŠãã ããã¯å€çšããŸãã
ã§ããŸã調ã§ã¯ãªã, ïœã§ãã åžžæ
(declarative form) ã§ä»¥åã¯Custom Instructions (ã«ã¹ã¿ã æç€º)ã«å
¥ããŠããŸãããé©å¿ãããªãããšãå€ãã®ã§æè¿ã¯æ¯ååœä»€ããŠããŸãâŠ
ãç·èšããæŠèŠãã¯ç·èª¬ã®Introductionã®éšåãä»ã®æç®ãGPTã§èŠçŽããŸãããææçµè·¯ã«ã€ããŠã¯ã¹ã«ãŒãããŸããâŠ

ç¶ããŠçç¶ããŸãšããŸãã
çç¶ã«ã€ããŠãŸãšããŠãã ãããããã«é »åºŠå¥ã«è¡šã«ããŠãã ããã
4.3 æ€æ», 蚺æ
èºåžè«çã®CTæèŠã«é¢ããè«æãæ€çŽ¢ãç°¡åãªèŠçŽãšãªã³ã¯, åŒçšæç®ãæç€ºããŠäžããã
[J Y;V:P]ã®åœ¢åŒã§J:Journal Y:year V:volume P:pageãäŸ [Intern Med 2023;1:1-5]
åæ§ã«ããã€ãè«æãåèš³ããŠwordã«åŒµãä»ãGPTã§èŠçŽããŠããããŸãã

äžæžããšããŠã¯ååã§ã¯ãªãã§ãããããåèæç® ( [éèªå 幎ïŒå·»ïŒããŒãž] ) ãæç« äžã«è¡šèšãã€ã€ã®æç« äœæã¯æçãšãªããŸãã
4.4 æ²»ç
Perplexity AIã䜿ãã°ããã«æ¢ãæéãçã, æç« ã®å 容ããã®ãŸãŸæµçšã§ãæçãå¯èœãšãªããããããŸãããäŸãã°Perplexityã§ãParagonimiasis treatment (èºåžè«ç æ²»ç)ã ãšããã¯ãŒãã§æ€çŽ¢ããŸãã

Answerãã³ããã, ShaperâDeepLã§ç¿»èš³ããŸã

web å šäœããåç §ãããŠããŸãã®ã§, åŒçšå ãäžè¬çãªããŒã ããŒãžã§ããå ŽåããããŸãããã®å Žå, æ€çŽ¢ã¯ãŒãã«ãpubmedããå«ãããšPubMedã ãã®åŒçšãšãªããŸãã
ãParagonimiasis treatment (èºåžè«ç æ²»ç)ã

4.5 ä»ã®å ±åãšã®æ¯èŒ, ç·åèå¯
å ã»ã©é¡äŒŒç ç©¶ (çäŸ) ãäœåãPaperPileã«æ€çŽ¢ããŠããããŸãããåãChatæ¬ã§æ¯èŒè¡šãäœæããŸãã
ãããã®è«æããå1åãã€çäŸãæœåºãå
šãŠè±èªã§æ¯èŒè¡šãäœæããŠãã ããã No, Author, Year,
Case (Age M or F), Symptoms, Imaging (CTæèŠ), Time to diagnosis, misdiagnosed disease
treatment
äžçªäžã«èªéšäŸ Author (ChatGPT) ãå ãã5åã§æ¯èŒè¡šã
äžéš, è±èªã«ãªã£ãŠããªãã£ãã, çè åãæããŠããããšããããç²ããèŠã€ãããŸããExcelã§äžããäœãããšãèããã°å€§å楜ã§ããÂ
æåŸã«æ¯èŒè¡š, èªéšäŸã®æ¯ãè¿ããåãChatæ¬ã§è¡ããŸãã
ãç·åèå¯ãäœæããŠãã ãããã ãã§ã¯ãããŸããªåœãããããã®ãªãæç« ããè¿ã£ãŠããŸãããããçšåºŠå
·äœçãªããã³ãããå¿
èŠã§ãã
æ¯èŒè¡šã®çäŸãšèªéšäŸãæ¯èŒãç·æ¬ã®ãç·åèå¯ããäœæããŠãã ãããç¹ã«Covid-19眹æ£åŸãšãã
ããšã§æç¶ããèºçç¶ãææåŸåšè³ªèºç, ãã®ä»ã®éå¥, 蚺æ, å蚺ã®éèŠãã«ã€ããŠãŸãšããŠäžããã
5. çºè¡šæºå (質çå¿ç察çãªã©)
5.1 質çå¿ç
ChatGPTã®è³ªçå¿çãäœæããæ§èœã¯é«ãå©çšããªãæã¯ãããŸããã
ä»åã®çäŸã§åŠäŒçºè¡šããã«ããã質çå¿çã®æºåãäžç·ã«ããŠãã ãããæ³å®ããã質åã
10åæããŠãã ããã
7. 蚺æãé
ããçç±ã«ã€ããŠãæš¡ç¯è§£çãçšæããŠãã ããã
PaperPile ã®Chatæ¬ã§å¯Ÿè©±ããŠããŸãã®ã§åèæç®ãèŠã€ããŠããŠãããŸãã
4. Covidã®èºçç¶ãšèºåžè«çã®èºçç¶ã®æš¡ç¯è§£çãšé¢é£ããè«æãã ããããªã³ã¯å ã¯å®åšããè«æã§ããããã¡ããGPTã«èŠçŽããŠããã質å察çãèããŠãããããšãã§ããŸãã

5.2 æé²ã®äœæ
ä»ãŸã§ã®Chatæ¬ã«ä»¥äžã®ããã³ãããå ¥åãæé²ãäœæããŸãã以äžã®åœ¢åŒã¯å ç§å°æ¹äŒã®ãã®ã§ããæåºå ã«ãã£ãŠéæå€æŽããŸãã
åŠäŒçºè¡šãäºå®ããŠããŸããæŒé¡æé²ã以äžã®æ¡ä»¶ã®ããš, åºåäŸã®éã600æåã§äœæããŠäžããã
説æã¯äžèŠã§çµæã®ã¿ãè¿ããŠãã ããã
æ¡ä»¶ïŒ
â ââ²ã¯è¡šç€ºäžèŠã§æååã«çœ®æããŠãã ããã
â ã¿ã€ãã«äžè¡ã§
â² æŒè
ã®æå±ãæœèšå çºè¡šè
çäŸïŒ 幎霢, æ§å¥
çŸç
æŽïŒ çµéã300æåã§èŠçŽ
èå¯ïŒèå¯ã100æåã§èŠçŽ
ããŒã¯ãŒãïŒããŒã¯ãŒãã3åèªã§
åºåäŸïŒ
â
â²
ãçäŸãâ ã䞻蚎ãâ ãçŸç
æŽãâ ãèå¯ãâ
ããŒã¯ãŒãïŒâ 
ãªããä»å調åãæªããããããã衚瀺ãããŸããã§ããã®ã§æåã§ãïŒãã«å€æŽããŸããã
宿
æ®éã«æåã§ãã¯ãŒãã€ã³ãã«ã³ããããŠããŸãããã®æ¹æ³ãäžçªæ©ããšæãããŸãã



ChatGPTãçšããåŠäŒã¹ã©ã€ãã®äœææ³ã«é¢ããŠ, ãããŸã§ãããããªæ¹æ³ã玹ä»ããŸããã, çµå±ã¯åå§çãªæ¹æ³ãäžçªå¹ççã«, 楜ã«äœãããšãã§ããŸãããèªååãªã©äžéå端ã«èŠæãªããšãç¡çãããããã®ã§ã¯ãªã, æç« èŠçŽ, æ€çŽ¢, æ€æ»å€, 衚ã®äœæãªã©åŸæãªããšã ãããããã®ãæãå¹ççãšæããŸãã
6. æ¯ãè¿ã AIã®å眪
ãã®èšäºã宿ããããã (2023/10) ããç»åèªè (GPT4-V), ç»åçæ (DALL-E3) ã®å®è£ ã®ãã¥ãŒã¹ãããå°æ¥æ§ã®æåŸ ã«ã€ããŠæ¥ã å ±éãããŠããŸããåæã«äºååŠç¿å ã®èäœæš©ããã¿ã§äžç©ãªãã¥ãŒã¹ãäžéšãªãããŠããŸãã
GPT4ããªãªãŒã¹ãããåœå, äžéã§ã¯ãAIã§ãããªããšãåºæ¥ãŸããããšé£æ¥SNSã§çºä¿¡, ãç¥ãéšãã§èªåèªèº«ãåçŸæ§ãªã©ããŸã確ãããã«ç¡è²¬ä»»ãª?æçš¿ãããŠããŸãããããããå幎, æã£ãã»ã©æ®åã¯ãªãããŒã ããã£ããããªå°è±¡ã§ãããšããèš³ã§ä»å, GPTã«çç±ãåæããŠããããŸããã
æã£ãã»ã©AI (ChatGPT=ããªã) ã¯äžéã«æµžéããªãã£ããšæããŸãããã®çç±ãäžç·ã«èããŠ
äžãããGPTãšäžç·ã«èããŠãŸãšããŸããã
1. æåŸ å€ãšçŸå®ã®ã®ã£ãã:
éåºŠãªæåŸ : ã¡ãã£ã¢ãäžéšã®å®£äŒã«ãããäžèœããšã®ã©ããªã³ã°ã
çæçãªããŒã : äžéæ§ã®é¢å¿ã®é«ãŸãã çµæžçãªåæ©: ããžãã¹ãžã®å¿çšã«é¢ããéåºŠãªæåŸ ã
2. æè¡çã»æ å ±çãªéå£:
æè¡çããŒãã«: AIãæ©æ¢°åŠç¿ã®å®çšã«ã¯é«åºŠãªã¹ãã«ãããŒã«ã®ç¥èãå¿ èŠã
æ å ±éå€: AIã®åŠç¿è³æãæ å ±ã®æŽªæ°Žã ãã¬ãŒãã³ã°ããŒã¿ã®äžè¶³ãéææ§ã®æ¬ åŠã
3.å«ççã»ç€ŸäŒçãªåé¡:
ãã©ã€ãã·ãŒãåèŠãå ¬å¹³æ§ã«é¢ããåé¡ã ã»ãã¥ãªãã£ã®åé¡ãéææ§ã®æ¬ åŠã 人éã®ä¿¡é Œã®æ¬ åŠãæåçã»æŽå²çãªèæ¯ã
4. çµæžçã»å¶åºŠçãªéå£:
é«ãã³ã¹ã: AIã®å°å ¥ãéçšã«é¢é£ããã³ã¹ãã èŠå¶ãšæ³åŸ: AIã®äœ¿çšã«é¢ããæ³çå¶çŽã
å®é, åšãã®AIã«èå³ããªãã²ãšããèãæ¹å€ç, æ¶æ¥µçãªçç±ãšããŠ, ã䜿ã£ããã©åãã€ã, æã£ãåçãããªãã, ãé£ããã, ãæ å ±æŒæŽ©ãªã©ãæãããªã©ã«éçŽãããŸãã
ããããã®åã«æ¥æ¬ã§ã¯å©çšçã7%ãš, ããããèªç¥åºŠãäœã, ãAIäœãã?ãç¶æ ã«è¿ãç¶æ³ã§ããæè¿, å人çã«ã¯ãŸã£ãŠããèªå·±æ¡ç¹ãããŠããããŸãã
å
ã»ã©æãã4ã€ã®åå ããããã100ç¹æºç¹ã§æ¡ç¹ããŠãã ããã1. æåŸ å€ãšçŸå®ã®ã®ã£ãã: 85ç¹
ã¡ãã£ã¢ã宣äŒã«ããéåºŠãªæåŸ ã¯ãAIã®æ®åã«ãããŠå€§ããªéå£ãšãªãåŸãŸããç¹ã«ãå®éã®æ§èœãèœåãæåŸ ãäžåãå Žåã倱ææããAIã®æ¡çšãç¶ç¶çãªå©çšãæžå°ããå¯èœæ§ããããŸãã
2. æè¡çããŒãã«: 70ç¹
AIæè¡ã¯éåžžã«è€éã§ããããã®å®è£ ãéçšã«ã¯é«åºŠãªã¹ãã«ãç¥èãå¿ èŠãšãããå Žåãå€ãããŸããååãªãã¬ãŒãã³ã°ããŒã¿ãéææ§ãäžè¶³ããŠããå ŽåãAIã®å®çšåã«å¶çŽãçããããšããããŸãã
3. å«ççã»ç€ŸäŒçãªåé¡: 90ç¹
AIã®æ®åã«ãããŠããã©ã€ãã·ãŒãåèŠãå ¬å¹³æ§ãªã©ã®å«ççã»ç€ŸäŒçãªåé¡ã¯éåžžã«éèŠã§ããç¹ã«ã人ã ã®ä¿¡é ŒãåŸãããã«ã¯ããããã®åé¡ãé©åã«å¯ŸåŠããããšãå¿ èŠäžå¯æ¬ ã§ãã
4. çµæžçã»å¶åºŠçãªéå£: 80ç¹
AIæè¡ã®å°å ¥ãéçšã«ãããã³ã¹ãããæ³çå¶çŽãªã©ã®å¶åºŠçãªéå£ããAIã®æ®åãé»å®³ããèŠå ãšãªãåŸãŸããç¹ã«ãåæã®å°å ¥ã³ã¹ããé«ãå ŽåããèŠå¶ã峿 Œã§ããå ŽåãäŒæ¥ãå£äœã®AIã®æ¡çšãèºèºãããå¯èœæ§ããããŸãã
çµæžçãªçç±, å°å ¥åæè²»çšãªã©ã¯äŒç€Ÿã¬ãã«ã®åé¡ã§ãã®ã§ä»åã¯1. æåŸ å€ãšçŸå®ã®ã®ã£ããã«ã€ããŠæãäžããããšæããŸããæåŸ ããŠããã®ã«äœ¿ããªããšããçŸè±¡ã¯çœªæ·±ããšæããŸããäŸãã°GPTã§æ€çŽ¢ããŠ, æ¶ç©ºè«æãæç€ºããã, åãæç€ºããã, ç°¡åãªèšç®åé¡ãè§£ãããŠééã£ãèšç®çµæãåºããŠãããªã©èœèã¯å€§ãããšæããŸãã
äŸãããªãWordã§1000æåã®æç« æžãããäœæåã誀åããã, Word (ã€ã«ã«)ã誀åè±åã¯èªåã§èšæ£ããŠãã ãããã, Excelã§ã»ã«ã®éèšãããŠãæ°ããŒã»ã³ãã¯èª€å·®ããããããããŸããã, Googleæ€çŽ¢ã§ãã®ãžãã§ããããã®ã©ãŒã¡ã³å±ãæ€çŽ¢ããŠãããå± æ5å (ååšããªãåºãããããŸãã)ããšèšããããããªãã®ã§, ãã®ãããªããšããããšãã®ããŒã«ã¯äºåºŠãšäœ¿ããªããããããŸããã

AIã®èœãšã穎ãšããŠå人çã«åé¡ãšãªãã®ã¯ãåºæ¥ããããããªãããšããAIã«ãããŠæéã倧éã«æµªè²»ããããšã§ããAIã®é²æ©ã¯åãŸãã, äœãåºæ¥ãŠäœãåºæ¥ãªãã®ãAIéçºè , ããããããGPTèªèº«ãç¥ããªããããããŸããã

äŸãã°AIã®åŸæãªäœæ¥, èŠçŽãªã©ã¯ããã³ãããäœæããæéãã»ãšãã©ãªã, 確å®ã«è¿çããŸãã®ã§å§åçãªæéå¹çã«ã€ãªãããŸããããã, é«åºŠãªäœæ¥, èŠæãªäœæ¥, äŸãã°è€éãªã°ã©ãäœæãé«åºŠãªèå¯æç« ãªã©ã¯

ããã³ãããäœæããŠã§ããªãã£ãå Žå, ããæå³, GPTã¯åªç§ã§ãåºæ¥ãŸããããšã¯èšããã«, ããã®ããã«æ¹æ³ãå€ãããã©ãã§ãããã?ããšã¢ã€ãã¢ãç¡æ°ã«ææ¡ããŠããŸããäœåã詊ããã¡ã«æçµçã«ããã³ãããåºæ¥ããè¯ãã§ããåºæ¥ãªãã£ãå Žå, æéãæµªè²»ããã ãã«ãªããŸãã

çè
ãå«ããŠäžéå端ã«åºæ¥ãããšãããã°ã§ç޹ä»ããããšã¯å€ãã®èªè
ã®æéã奪ããšãã眪深ãçµæã«ãªããŸãã
ãããŸã§ã®å
容ããã§ããã§ããè©æ¬º (False Hope and Time-Waste by GPT)ããšããŠãŸãšããŠ
äžããããã§ããã§ããè©æ¬º (False Hope and Time-Waste by GPT)ã:
ãã®çšèªã¯ãAIãç¹ã«GPTã®æè¡ã«å¯ŸããéåºŠãªæåŸ ãšãå®éã®çµæãšã®éã®ã®ã£ãããæããŸããGPTãªã©ã®AIã¢ãã«ã¯éåžžã«å€æ©èœã§ãããããŸããŸãªã¿ã¹ã¯ãåŠçããèœåããããŸãããããã«ããããããå šãŠã®åé¡ãå®ç§ã«è§£æ±ºããããã§ã¯ãããŸãããéåºŠãªæåŸ ãæã¡AIãå©çšãããŠãŒã¶ãŒã¯ãæåŸ ããçµæãšAIã®åºåãšã®éã«ã®ã£ãããæããããšãå€ãããã®ã®ã£ããã«ãã£ãŠããŠãŒã¶ãŒã¯æ·±ãèœèãæããäžã«ã¯ãã®çµéšããAIãäºåºŠãšäœ¿ãããšããªã人ãåºãŠããŸããç¹ã«å°éçãªå 容ãè€éãªåé¡è§£æ±ºãæåŸ ããå Žé¢ã§ã®èœèã¯å€§ããããã®çŸè±¡ãé¿ããããã«ã¯ãAIæè¡ã®èœåãšéçãæ£ç¢ºã«çè§£ããé©åãªã¿ã¹ã¯ã«é©åã«äœ¿çšããããšãéèŠã§ãã
ãšããèš³ã§ä»åŸã¯, ãªãã¹ãäžéå端ã«åºæ¥ãããšã¯èªåŒµããã«, åºæ¥ãããšåºæ¥ãªãããšãæç€ºããŠèšäºäœæã«èšã¿ãããšæããŸãã
AIããŒã ããã£ãŠæ¥ããšäºæ³ããŠ, çè
ãå«ãèªç§°AIç ç©¶å®¶ã¯AI掻çšè¡ã玹ä»ããŠããŸããã
ãããå€å°ãåºæ¥ãåºæ¥ãè©æ¬ºãã®åœ±é¿ãããæã£ãã»ã©æµžéããªãã£ãã§ãããã®ãŸãŸã§ã¯
AIããŒã ããæ¥ãæ¥ãè©æ¬º (Ever-Coming GPT Boom Fallacy) ãã远å ããããåŸãŸããããæ¥ãæ¥ãè©æ¬º (Ever-Coming GPT Boom Fallacy)ãã¯ãAIãæè¡é©åœã®ããŒã ãéè¿ã«ãã£ãŠãããšã®éåºŠãªæåŸ ããçããçŸè±¡ãæããŸããå€ãã®ã¢ããŠã³ã¹ãã¡ãã£ã¢ã®å ±éã«ãããAIã®å€§é©åœãç®åã«è¿«ã£ãŠãããã®ããã«æãããããå®éã«ã¯ãã®ãããªå€§ããªå€åã蚪ããã人ã ãèœèããç¶æ³ãæããŸããäŸãšããŠãSFæ ç»ã§æããããããªæªæ¥çãªæè¡ã®å®çŸãåŸ ãããäžæ¹ã§ãå®éã®çŸå Žã§ã¯ææžãã®ã«ã«ãããã³ã³ãæåã§ã®ããŒã¿å ¥åãšãã£ãå€é¢šãªäœæ¥ãç¶ããŠããç¶æ ãææããã®ã«äœ¿ãããŸãããã®æŠå¿µã¯ãæè¡ã®é²åãšããã«å¯Ÿãã人ã ã®æåŸ å€ãšã®ã®ã£ããã瀺åããŠããŸãã
ãåºæ¥ãåºæ¥ãè©æ¬ºããå©é·ããªããããªèšäºäœæãå¿æãããã§ããã¢ããã€ã¹ãé¡ãããŸãã
ãªãã»ã©åèã«ãªããŸãã
次åäºåã
ããè©æ¬ºãäžå
åŒã®æ«ã£åç»å Ž